mrmarket.ai
Stock Overview

Edwards Lifesciences Corp (EW)

NYSE · Healthcare · Medical Devices

Edwards Lifesciences Corp is a Healthcare company with a market capitalization of $51.99B and a trailing P/E ratio of 53.7.

Market Cap
$51.99B
P/E (TTM)
53.7
Forward P/E
30.1
Price/Sales
8.0
Price/Book
4.9
EV/EBITDA
29.3
Beta
0.85
EPS (TTM)
$1.68
Profit Margin
17.3%
ROE
9.2%
Short % of Float
2.0%
Days to Cover
2.5
52W High
$95.17
52W Low
$72.65

5-Year Price History

Latest Annual Financials · FY ending December 31, 2025

Revenue
$6.07B
Gross Profit
$4.74B
Operating Income
$1.64B
Net Income
$1.07B
Free Cash Flow
$1.33B
Total Debt
$622.80M
Cash & Equivalents
$2.94B
Shareholder Equity
$10.34B

Recent Quarterly Earnings (EPS)

QuarterReportedActual EPSEstimateSurprise
Q1 2026April 23, 2026$0.78$0.73+6.9%
Q4 2025February 10, 2026$0.58$0.62-6.4%
Q3 2025October 30, 2025$0.67$0.59+13.6%
Q2 2025July 24, 2025$0.67$0.62+8.1%
Q1 2025April 23, 2025$0.64$0.60+6.7%
Q4 2024February 11, 2025$0.59$0.55+6.4%

Short Interest

FINRA-reported short interest for semi-monthly settlement dates, published about nine business days after each settlement. Share counts are adjusted to the current split basis.

SettlementShares Short% of Shares OutDays to CoverChange
July 15, 202611,352,0191.95%2.5-1.0%
June 30, 202611,466,7641.97%2.1-2.8%
June 15, 202611,797,4662.03%2.4-3.0%
May 29, 202612,163,1592.09%2.3+6.8%
May 15, 202611,394,3371.96%2.5+8.1%
April 30, 202610,538,4521.81%1.7+12.9%
April 15, 20269,331,3591.60%2.0-6.4%
March 31, 20269,971,3561.71%2.3-8.9%

Other Medical Devices Stocks

ABT
Abbott Laboratories
$192.35B
SYK
Stryker Corporation
$128.32B
MDT
Medtronic PLC
$110.76B
BSX
Boston Scientific Corp
$73.25B
DXCM
DexCom Inc
$33.38B
GEHC
GE HealthCare Technologies Inc.
$32.80B
PHG
Koninklijke Philips NV ADR
$26.55B
STE
STERIS plc
$22.86B
EW vs ABTEW vs SYKEW vs MDT

Frequently Asked Questions

What is Edwards Lifesciences Corp's market cap?

As of August 13, 2026, Edwards Lifesciences Corp (EW) has a market capitalization of $51.99B.

What is Edwards Lifesciences Corp's P/E ratio?

Edwards Lifesciences Corp trades at a trailing price-to-earnings (P/E) ratio of 53.7. Its forward P/E is 30.1.

Does Edwards Lifesciences Corp pay a dividend?

Edwards Lifesciences Corp does not currently pay a dividend.

What sector is EW in?

Edwards Lifesciences Corp is in the Healthcare sector, specifically the Medical Devices industry.

What is Edwards Lifesciences Corp's short interest?

As of the July 15, 2026 FINRA settlement, 11,352,019 EW shares were sold short, or 1.95% of shares outstanding. Days to cover: 2.5. FINRA publishes short interest twice a month, about nine business days after each settlement date.

What was Edwards Lifesciences Corp's revenue?

In its latest reported fiscal year (ending December 31, 2025), Edwards Lifesciences Corp reported revenue of $6.07B and net income of $1.07B.

Ask your own questions about EW

Try mrmarket.ai free

Data as of August 13, 2026. Figures are sourced from company filings and market data and may be delayed or revised. For informational purposes only — not investment advice.